• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原激活物受体在细胞信号转导、固有免疫和炎症中的组装。

Plasminogen activator receptor assemblies in cell signaling, innate immunity, and inflammation.

机构信息

Department of Pathology, University of California, San Diego, California.

出版信息

Am J Physiol Cell Physiol. 2021 Oct 1;321(4):C721-C734. doi: 10.1152/ajpcell.00269.2021. Epub 2021 Aug 18.

DOI:10.1152/ajpcell.00269.2021
PMID:34406905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8560384/
Abstract

Tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) are serine proteases and major activators of fibrinolysis in mammalian systems. Because fibrinolysis is an essential component of the response to tissue injury, diverse cells, including cells that participate in the response to injury, have evolved receptor systems to detect tPA and uPA and initiate appropriate cell-signaling responses. Formation of functional receptor systems for the plasminogen activators requires assembly of diverse plasma membrane proteins, including but not limited to: the urokinase receptor (uPAR); integrins; -formyl peptide receptor-2 (FPR2), receptor tyrosine kinases (RTKs), the -methyl-d-aspartate receptor (NMDA-R), and low-density lipoprotein receptor-related protein-1 (LRP1). The cell-signaling responses elicited by tPA and uPA impact diverse aspects of cell physiology. This review describes rapidly evolving knowledge regarding the structure and function of plasminogen activator receptor assemblies. How these receptor assemblies regulate innate immunity and inflammation is then considered.

摘要

组织型纤溶酶原激活物(tPA)和尿激酶型纤溶酶原激活物(uPA)是丝氨酸蛋白酶,是哺乳动物系统中纤维蛋白溶解的主要激活剂。由于纤维蛋白溶解是组织损伤反应的一个重要组成部分,包括参与损伤反应的细胞在内的各种细胞都进化出了受体系统来检测 tPA 和 uPA,并启动适当的细胞信号反应。纤溶酶原激活物功能性受体系统的形成需要组装多种质膜蛋白,包括但不限于:尿激酶受体(uPAR);整合素;甲酰肽受体-2(FPR2),受体酪氨酸激酶(RTKs),-甲基-d-天冬氨酸受体(NMDA-R)和低密度脂蛋白受体相关蛋白-1(LRP1)。tPA 和 uPA 引发的细胞信号反应影响细胞生理学的各个方面。本综述描述了关于纤溶酶原激活物受体组装的结构和功能的快速发展的知识。然后考虑了这些受体组装如何调节先天免疫和炎症。

相似文献

1
Plasminogen activator receptor assemblies in cell signaling, innate immunity, and inflammation.纤溶酶原激活物受体在细胞信号转导、固有免疫和炎症中的组装。
Am J Physiol Cell Physiol. 2021 Oct 1;321(4):C721-C734. doi: 10.1152/ajpcell.00269.2021. Epub 2021 Aug 18.
2
Tissue-type plasminogen activator regulates macrophage activation and innate immunity.组织型纤溶酶原激活剂调节巨噬细胞活化和固有免疫。
Blood. 2017 Sep 14;130(11):1364-1374. doi: 10.1182/blood-2017-04-780205. Epub 2017 Jul 6.
3
Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.尿激酶型纤溶酶原激活剂在缺乏其受体或组织型纤溶酶原激活剂的情况下对纤维蛋白清除有效。
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5899-904. doi: 10.1073/pnas.93.12.5899.
4
PAI1 blocks NMDA receptor-mediated effects of tissue-type plasminogen activator on cell signaling and physiology.PAI1 可阻断组织型纤溶酶原激活物对细胞信号转导和生理功能的 NMDA 受体介导作用。
J Cell Sci. 2018 Jul 26;131(14):jcs217083. doi: 10.1242/jcs.217083.
5
Regulation and interactions in the activation of cell-associated plasminogen.细胞相关纤溶酶原激活中的调节与相互作用。
Cell Mol Life Sci. 2004 Nov;61(22):2840-58. doi: 10.1007/s00018-004-4230-9.
6
A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.神经元型尿激酶型纤溶酶原激活剂(uPA)与星形胶质细胞型uPA受体(uPAR)之间的相互作用促进缺血性脑内星形胶质细胞激活和突触恢复。
J Neurosci. 2017 Oct 25;37(43):10310-10322. doi: 10.1523/JNEUROSCI.1630-17.2017. Epub 2017 Sep 20.
7
The fibrinolytic system: A new target for treatment of depression with psychedelics.纤维蛋白溶解系统:治疗致幻剂所致抑郁症的新靶点。
Med Hypotheses. 2017 Mar;100:46-53. doi: 10.1016/j.mehy.2017.01.013. Epub 2017 Jan 23.
8
Plasminogen Activation System in Rectal Adenocarcinoma.直肠腺癌中的纤溶酶原激活系统
Anticancer Res. 2015 Nov;35(11):6009-15.
9
Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System.尿激酶型纤溶酶原激活剂(uPA)与uPA受体(uPAR)结合可促进中枢神经系统中的轴突再生。
J Biol Chem. 2017 Feb 17;292(7):2741-2753. doi: 10.1074/jbc.M116.761650. Epub 2016 Dec 16.
10
Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.尿激酶型纤溶酶原激活剂、尿激酶型纤溶酶原激活剂受体及其抑制剂在春季角结膜炎中的作用
Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1364-70. doi: 10.1167/iovs.04-1196.

引用本文的文献

1
The urokinase receptor/uPAR is a major effector of p53 gain-of-function mutations in gemcitabine-treated pancreatic ductal adenocarcinoma.尿激酶受体/uPAR是吉西他滨治疗的胰腺导管腺癌中p53功能获得性突变的主要效应分子。
J Biol Chem. 2025 Aug 7;301(9):110561. doi: 10.1016/j.jbc.2025.110561.
2
Unveiling the Multifaceted Role of HP6: A Critical Regulator of Humoral Immunity in (Lepidoptera: Saturniidae).揭示HP6的多面角色:一种鳞翅目大蚕蛾科昆虫体液免疫的关键调节因子
Int J Mol Sci. 2025 May 9;26(10):4514. doi: 10.3390/ijms26104514.
3
The antiprotease Spink7 promotes inflammation resolution by modulating multiple proteases activities during wound healing.抗蛋白酶Spink7通过在伤口愈合过程中调节多种蛋白酶的活性来促进炎症消退。
Clin Transl Med. 2025 Apr;15(4):e70291. doi: 10.1002/ctm2.70291.
4
The dynamic role of soluble urokinase plasminogen activator receptor (suPAR) in monitoring coagulation dysfunction during COVID-19 progression: a review.可溶性尿激酶型纤溶酶原激活物受体(suPAR)在监测新型冠状病毒肺炎(COVID-19)进展过程中凝血功能障碍的动态作用:综述
Ann Med Surg (Lond). 2024 Dec 19;87(2):635-640. doi: 10.1097/MS9.0000000000002791. eCollection 2025 Feb.
5
Candidate serum protein biomarkers for active pulmonary tuberculosis diagnosis in tuberculosis endemic settings.结核流行地区活动性肺结核诊断的候选血清蛋白标志物。
BMC Infect Dis. 2024 Nov 21;24(1):1329. doi: 10.1186/s12879-024-10224-3.
6
Transcriptomic analysis of profibrinolytic and fibrinolytic inhibitor genes in COVID-19 patients.新冠病毒感染患者中纤溶酶原激活物和纤溶酶原激活物抑制剂基因的转录组分析
Narra J. 2024 Aug;4(2):e843. doi: 10.52225/narra.v4i2.843. Epub 2024 Jul 5.
7
The emerging role of tranexamic acid and its principal target, plasminogen, in skeletal health.氨甲环酸及其主要靶点纤溶酶原在骨骼健康中的新作用。
Acta Pharm Sin B. 2024 Jul;14(7):2869-2884. doi: 10.1016/j.apsb.2024.03.033. Epub 2024 Mar 30.
8
Urokinase-Type Plasminogen Activator Receptor (uPAR) in Inflammation and Disease: A Unique Inflammatory Pathway Activator.尿激酶型纤溶酶原激活物受体(uPAR)在炎症与疾病中的作用:一种独特的炎症途径激活剂
Biomedicines. 2024 May 24;12(6):1167. doi: 10.3390/biomedicines12061167.
9
Tissue-plasminogen activator effects on the phenotype of splenic myeloid cells in acute inflammation.组织型纤溶酶原激活剂对急性炎症中脾脏髓样细胞表型的影响。
J Inflamm (Lond). 2024 Feb 14;21(1):4. doi: 10.1186/s12950-024-00375-0.
10
Macrophage Function Modulated by tPA Signaling in Mouse Experimental Kidney Disease Models.tPA 信号对小鼠实验性肾病模型中巨噬细胞功能的调节。
Int J Mol Sci. 2023 Jul 4;24(13):11067. doi: 10.3390/ijms241311067.

本文引用的文献

1
Protease Nexin-1 in the Cardiovascular System: Wherefore Art Thou?心血管系统中的蛋白酶连接素-1:汝在何处?
Front Cardiovasc Med. 2021 Mar 31;8:652852. doi: 10.3389/fcvm.2021.652852. eCollection 2021.
2
Fibrinolysis: A Primordial System Linked to the Immune Response.纤维蛋白溶解:与免疫反应相关的原始系统。
Int J Mol Sci. 2021 Mar 26;22(7):3406. doi: 10.3390/ijms22073406.
3
Enzymatically Inactive Tissue-Type Plasminogen Activator Reverses Disease Progression in the Dextran Sulfate Sodium Mouse Model of Inflammatory Bowel Disease.酶失活组织型纤溶酶原激活剂逆转葡聚糖硫酸钠诱导的炎症性肠病小鼠模型的疾病进展。
Am J Pathol. 2021 Apr;191(4):590-601. doi: 10.1016/j.ajpath.2021.01.001. Epub 2021 Jan 17.
4
TLR4 Response to LPS Is Reinforced by Urokinase Receptor.尿激酶受体增强 TLR4 对 LPS 的反应。
Front Immunol. 2020 Dec 9;11:573550. doi: 10.3389/fimmu.2020.573550. eCollection 2020.
5
Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?固有免疫信号和蛋白水解途径在新冠病毒 2 型(SARS-CoV-2)引起的新冠肺炎(Covid-19)中的转归或恶化:关键治疗靶点?
Front Immunol. 2020 May 28;11:1229. doi: 10.3389/fimmu.2020.01229. eCollection 2020.
6
Tissue-type plasminogen activator-primed human iPSC-derived neural progenitor cells promote motor recovery after severe spinal cord injury.组织型纤溶酶原激活剂预处理的人诱导多能干细胞衍生的神经祖细胞促进严重脊髓损伤后的运动功能恢复。
Sci Rep. 2019 Dec 17;9(1):19291. doi: 10.1038/s41598-019-55132-8.
7
Tissue-type plasminogen activator selectively inhibits multiple toll-like receptors in CSF-1-differentiated macrophages.组织型纤溶酶原激活物选择性抑制 CSF-1 分化的巨噬细胞中的多种 toll 样受体。
PLoS One. 2019 Nov 7;14(11):e0224738. doi: 10.1371/journal.pone.0224738. eCollection 2019.
8
A multimolecular signaling complex including PrP and LRP1 is strictly dependent on lipid rafts and is essential for the function of tissue plasminogen activator.一个包含朊蛋白和 LRP1 的多分子信号复合物严格依赖于脂筏,对于组织型纤溶酶原激活物的功能至关重要。
J Neurochem. 2020 Feb;152(4):468-481. doi: 10.1111/jnc.14891. Epub 2019 Oct 25.
9
Tissue-type plasminogen activator neutralizes LPS but not protease-activated receptor-mediated inflammatory responses to plasmin.组织型纤溶酶原激活物能中和 LPS,但不能中和纤溶酶激活的蛋白酶受体介导致炎反应。
J Leukoc Biol. 2019 Apr;105(4):729-740. doi: 10.1002/JLB.3A0818-329RRR. Epub 2019 Jan 28.
10
Wound Healing: A Cellular Perspective.创伤愈合:细胞视角。
Physiol Rev. 2019 Jan 1;99(1):665-706. doi: 10.1152/physrev.00067.2017.